Ingevity Corporation NGVT
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 305.10M | 314.10M | 258.00M | 255.10M | 333.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 305.10M | 314.10M | 258.00M | 255.10M | 333.10M |
| Cost of Revenue | 172.30M | 175.10M | 141.60M | 167.30M | 199.20M |
| Gross Profit | 132.80M | 139.00M | 116.40M | 87.80M | 133.90M |
| SG&A Expenses | 38.10M | 39.00M | 40.70M | 41.60M | 44.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 218.70M | 220.20M | 189.00M | 216.30M | 250.30M |
| Operating Income | 86.40M | 93.90M | 69.00M | 38.80M | 82.80M |
| Income Before Tax | 68.90M | 50.70M | 30.20M | -105.30M | 62.20M |
| Income Tax Expenses | 17.80M | 10.90M | 6.80M | -26.50M | 21.40M |
| Earnings from Continuing Operations | 51.10M | 39.80M | 23.40M | -78.80M | 40.80M |
| Earnings from Discontinued Operations | -1.80M | -4.50M | 36.40M | -5.80M | 2.70M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.30M | 35.30M | 59.80M | -84.60M | 43.50M |
| EBIT | 86.40M | 93.90M | 69.00M | 38.80M | 82.80M |
| EBITDA | 106.40M | 114.80M | 90.40M | 66.60M | 110.80M |
| EPS Basic | 1.44 | 1.02 | 1.70 | -2.37 | 1.20 |
| Normalized Basic EPS | 1.32 | 1.37 | 0.91 | 0.12 | 1.11 |
| EPS Diluted | 1.41 | 1.00 | 1.66 | -2.37 | 1.17 |
| Normalized Diluted EPS | 1.29 | 1.35 | 0.90 | 0.12 | 1.09 |
| Average Basic Shares Outstanding | 34.26M | 34.69M | 35.26M | 35.70M | 36.31M |
| Average Diluted Shares Outstanding | 34.85M | 35.28M | 36.02M | 35.70M | 36.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |